Richard A Banas,Vivienne S Marshall,Catherine J Trumpower
申请号：
US13942877
公开号：
US09138443B2
申请日:
2013.07.16
申请国别(地区):
US
年份:
2015
代理人:
摘要：
The invention is directed to novel methods for modulating inflammatory and/or immune responses. Such methods utilize compositions comprising extraembryonic cells (herein referred to as EE cells) including but not limited to extraembryonic HLA-G positive cells (herein referred to as EHP cells) and amnion-derived multipotent progenitor cells (herein referred to as AMP cells) compositions comprising expanded EE cell populations, and/or cell lysates and/or conditioned media derived therefrom, alone or in combination with each other and/or in combination with various extracellular matrices and/or devices and/or other suitable active agents.
